Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage

Sci Rep. 2015 Dec 22:5:18599. doi: 10.1038/srep18599.

Abstract

Vestibular schwannomas (VSs) are the most common tumours of the cerebellopontine angle. Ninety-five percent of people with VS present with sensorineural hearing loss (SNHL); the mechanism of this SNHL is currently unknown. To establish the first model to study the role of VS-secreted factors in causing SNHL, murine cochlear explant cultures were treated with human tumour secretions from thirteen different unilateral, sporadic VSs of subjects demonstrating varied degrees of ipsilateral SNHL. The extent of cochlear explant damage due to secretion application roughly correlated with the subjects' degree of SNHL. Secretions from tumours associated with most substantial SNHL resulted in most significant hair cell loss and neuronal fibre disorganization. Secretions from VSs associated with good hearing or from healthy human nerves led to either no effect or solely fibre disorganization. Our results are the first to demonstrate that secreted factors from VSs can lead to cochlear damage. Further, we identified tumour necrosis factor alpha (TNFα) as an ototoxic molecule and fibroblast growth factor 2 (FGF2) as an otoprotective molecule in VS secretions. Antibody-mediated TNFα neutralization in VS secretions partially prevented hair cell loss due to the secretions. Taken together, we have identified a new mechanism responsible for SNHL due to VSs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Animals
  • Audiometry, Pure-Tone
  • Cochlea / drug effects
  • Cochlea / pathology*
  • Demography
  • Female
  • Fibroblast Growth Factor 2 / metabolism
  • Hair Cells, Auditory / drug effects
  • Hair Cells, Auditory / pathology
  • Hearing Loss, Sensorineural / complications
  • Hepatocyte Growth Factor / metabolism
  • Humans
  • Male
  • Mice
  • Middle Aged
  • Neurites / drug effects
  • Neurites / pathology
  • Neuroma, Acoustic / complications
  • Neuroma, Acoustic / metabolism*
  • Neutralization Tests
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism
  • Vascular Endothelial Growth Factor A / pharmacology
  • Young Adult

Substances

  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • Fibroblast Growth Factor 2
  • Hepatocyte Growth Factor